AbbVie Inc.
ABBV
$211.96
-$6.08-2.79%
NYSE
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 15.59% | -11.65% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 15.59% | -11.65% | |||
| Cost of Revenue | 8.60% | -8.96% | |||
| Gross Profit | 18.58% | -12.75% | |||
| SG&A Expenses | -0.96% | 11.64% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.80% | -2.96% | |||
| Operating Income | 42.54% | -26.66% | |||
| Income Before Tax | -6.44% | 173.20% | |||
| Income Tax Expenses | 64.78% | 116.56% | |||
| Earnings from Continuing Operations | -27.00% | 5,704.35% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 0.00% | -400.00% | |||
| Net Income | -27.06% | 5,945.45% | |||
| EBIT | 42.54% | -26.66% | |||
| EBITDA | 28.50% | -20.15% | |||
| EPS Basic | -27.27% | 4,087.29% | |||
| Normalized Basic EPS | 51.13% | -31.12% | |||
| EPS Diluted | -27.78% | 3,950.27% | |||
| Normalized Diluted EPS | 51.23% | -31.28% | |||
| Average Basic Shares Outstanding | 0.00% | -0.06% | |||
| Average Diluted Shares Outstanding | -0.06% | 0.17% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 0.36% | 1.02% | |||